PYXIS ONCOLOGY INC (PYXS) Stock Balance Sheet
NASDAQ:PYXS - Nasdaq - US7473241013 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 12.76M | 19.47M | 9.66M | 179.30M | 274.70M | |||
| Marketable Securities | 92.67M | 107.46M | 109.63M | N/A | N/A | |||
| Receivables | N/A | N/A | 21.00K | 600.00K | N/A | |||
| Other Current Assets | 6.44M | 5.51M | 5.29M | 6.80M | 4.00M | |||
| Total Current Assets | 111.87M | 132.44M | 124.60M | 186.60M | 278.70M | |||
| Non-Current Assets | ||||||||
| PPE Net | 21.45M | 22.14M | 24.81M | 24.80M | 1.20M | |||
| Intangibles | 2.54M | 2.60M | 24.31M | N/A | N/A | |||
| Other Non-Current Assets | N/A | N/A | N/A | 0.00 | 100.00K | |||
| Total Non-Current Assets | 24.00M | 24.74M | 49.12M | 24.80M | 1.30M | |||
| TOTAL ASSETS | 135.87M | 157.18M | 173.73M | 211.40M | 280.00M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 11.58M | 12.18M | 13.85M | 23.40M | 6.50M | |||
| Accounts Payable | 2.85M | 4.86M | 3.90M | 7.10M | 12.00M | |||
| Other Current Liabilities | N/A | 643.00K | 8.02M | 1.10M | 300.00K | |||
| Total Current Liabilities | 14.43M | 17.68M | 25.76M | 31.60M | 18.70M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 80.00K | 100.00K | 0.00 | 0.00 | 0.00 | |||
| Deferred Taxes/Income | N/A | 0.00 | 2.16M | N/A | N/A | |||
| Other Non-Current Liabilities | 18.25M | 18.65M | 20.10M | 18.90M | 0.00 | |||
| Total Non-Current Liabilities | 18.33M | 18.75M | 22.26M | 19.00M | 0.00 | |||
| TOTAL LIABILITIES | 32.76M | 36.43M | 48.02M | 50.60M | 18.70M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -384.71M | -363.56M | -286.23M | -212.40M | -91.70M | |||
| Additional Paid In Capital | 487.71M | 484.08M | 411.82M | 373.20M | 353.00M | |||
| Common Shares | 62.00K | 60.00K | 45.00K | 0.00 | 0.00 | |||
| Other Shareholders' Equity | 49.00K | 170.00K | 63.00K | N/A | N/A | |||
| Shares Outstanding | 61.63M | 59.97M | 44.75M | 35.10M | 32.20M | |||
| Tangible Book Value per Share | 1.63 | 1.97 | 2.27 | 4.58 | 8.11 | |||
| Total Shareholders' Equity | 103.10M | 120.75M | 125.70M | 160.80M | 261.30M | |||
| TOTAL LIABILITIES AND EQUITY | 135.87M | 157.18M | 173.73M | 211.40M | 280.00M | |||
| Statistics | ||||||||
| Debt/Equity | 0.00 | 0.00 | N/A | N/A | N/A | |||
| Current Ratio | 7.75 | 7.49 | 4.84 | 5.91 | 14.90 | |||
| Return On Assets (ROA) | -70.09% | -49.20% | -42.47% | -57.11% | -27.14% | |||
| Return On Equity (ROE) | -92.37% | -64.04% | -58.70% | -75.07% | -29.08% | |||
All data in USD , ROIC based on taxRate of 0.21